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Endovascular management of juxtarenal
aneurysms with fenestrated endovascular grafting
Roy K. Greenberg, MD, Stephan Haulon, MD, Sean P. Lyden, MD, Sunita D. Srivastava, MD, Adrian
Turc, MD, Matthew J. Eagleton, MD, Timur P. Sarac, MD, and Kenneth Ouriel, MD, Cleveland, Ohio
Purpose: To evaluate the technical feasibility and short-term results of juxtarenal aneurysm repair with an endovascular
graft that incorporated the visceral aortic segment with graft material.
Methods: Patients were studied prospectively after the implantation of an endovascular device with graft material
extending proximal to the renal arteries, variably incorporating the superior mesenteric and celiac arteries. All patients
were deemed to be high risk with respect to open surgical repair and had compromised proximal neck anatomy. Proximal
neck lengths were <10 mm, or <15 mm with a challenging morphology (funnel shape or extensive thrombus).
Fenestrations within the graft material were customized to accommodate visceral and renal vessels on the basis of
computerized tomography (CT), angiography, or intravascular ultrasound data. Selected visceral ostia were protected
with balloon-expandable stents after partial endograft deployment. All patients were evaluated with CT and kidney,
ureters, and bladder x-ray at discharge and at 1, 6, and 12 months. Visceral duplex scan studies were performed at 1, 6,
and 12 months.
Results: A total of 22 patients were enrolled in the study. Sixteen patients had short proximal necks (3-10 mm), and six
had compromised necks of 10 to 15 mm in length. Endograft design included bifurcated (20) and tube (2) systems. All
prostheses were implanted successfully without the acute loss of any visceral arteries. A total of 58 visceral vessels were
incorporated (mean, 2.6 per patient) and most commonly included both renal arteries and the superior mesenteric artery.
The mean follow-up was 6 months. There were no deaths within 30 days and no aneurysm-related deaths during the
follow-up period. Two early (<30 days) and two late secondary interventions were performed, inclusive of two visceral
artery stenoses detected with duplex scanning. The 30-day endoleak rate was 4.5%. The aneurysm sac decreased greater
than 5 mm in 53 % of patients at 6 months and three of four patients at 12 months. Three patients developed renal
insufficiency, only one of which required temporary hemodialysis.
Conclusions: The placement of an endovascular prosthesis with graft material that incorporates the visceral arteries is
technically feasible. The occurrence of endoleaks appears to be relatively low. The increased sealing and fixation zones in
this patient population should limit the late development of proximal endoleak or migration; however, this situation will
require more patients and extended follow-up. (J Vasc Surg 2004;39:279-87.)
Estimates suggest that approximately 50% of patients
with abdominal aortic aneurysms will be candidates for
endovascular repair on the basis of anatomic exclusion
criteria. The recent approval of the Excluder (W.L. Gore,
Flagstaff, Ariz) and the Zenith (Cook Inc, Bloomington,
Ind) by the Food and Drug Administration (FDA) increase
the versatility of endovascular repair allowing for treatment
for patients with smaller, more complex iliac anatomy, and
larger diameter proximal necks. Several reports of un-
desirable late sequelae associated with venous devices, such
as migration1-4 and rupture5-7 have caused concern among
clinicians performing these procedures. Despite the incor-
poration of improved proximal fixation mechanisms with
the Zenith device (suprarenal stent with barbs), the inclu-
sion criteria for participation in the phase II U.S. trial and,
consequently, the commercial instructions for use require
an adequate proximal neck length of 15 mm. The treat-
ment of shorter necks with alternative devices has been
described8; however, the margin for technical error,
limited sealing stent to aortic wall apposition, and a
decreased fixation region have swayed most interven-
tionalists from treating this patient population. How-
ever, for the patient without an open surgical option who
is still considered to have a reasonable life expectancy,
aneurysm repair might be warranted. Surgical repair, in
this setting, is more challenging than infrarenal aneu-
rysms, as many will require suprarenal or supraceliac
clamping, which has been associated with a greater blood
loss,9 and potentially worse outcomes.10 Consequently,
the advent of endovascular devices capable of incorpo-
rating the renal and visceral arteries that provide equiv-
alent durability to open repair would be a valuable tool
to improve patient outcomes. The development and
initial clinical implants with this fenestrated device, man-
ufactured by Cook Inc, were carried out by Anderson,
Stanley, and Lawrence-Brown and have been previously
reported.11,12
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MATERIAL AND METHODS
From August 2001 to December 2002, 22 patients
were treated electively for juxtarenal abdominal aortic an-
eurysm with a fenestrated endovascular Zenith device. All
patients were considered to be at high risk for complica-
tions if they were to undergo an open surgical repair. Most
commonly this risk related to uncorrectable coronary dis-
ease, severe pulmonary dysfunction, or multiple prior ab-
dominal surgeries. Informed consent, approved by the
Institutional Review Board, was obtained for all research
subjects.
Endograft design. Preoperative assessment of pa-
tients included high-resolution helical computerized to-
mography (CT) scans that incorporated the distal descend-
ing thoracic aorta to the profunda femoris. Selectively,
angiography, magnetic resonance imaging, and intravascu-
lar ultrasound scanning were used. Traditional measure-
ments were obtained (proximal and distal neck lengths and
diameters, angulation, and aneurysm morphology). Addi-
tional attention was given to the visceral aortic segment.
The ostial diameters of each vessel, their relative distances
from the superior mesenteric artery, and orientations from
which they arise from an aortic cross-section were recorded.
Device design was intended to maximize the proximal
sealing zone, accommodate native arterial angulation, and
provide durable fixation. The initial device used was a
two-piece modular bifurcated system. This system evolved
into a tubular proximal component that incorporated the
desired visceral segment, which was then coupled with a
separate bifurcate system, in conjunction with one or two
limb extensions (Fig 1), similar to the standard Zenith
previously described.13 The areas of overlap for the tubular
and bifurcate sections were intentionally long, preferably
greater than 4 cm.
Three types of fenestrations were available to accom-
modate the visceral vessels. A small fenestration, with di-
mensions ranging from 4 to 6 mm in width and 4 to 8mm
in height, could be created a minimum of 15 mm inferior to
the proximal aspect of the graft. This type of fenestration
had no crossing struts from the sealing stent and was
intended to be used in conjunction with an additional
balloon-expandable stent. Alternatively, a larger fenestra-
tion with a diameter between 9 and 12 mm could be
created at least 10 mm below the top of the fabric. A
portion of the large fenestration was traversed by one of the
struts of the proximal sealing Z-stent and, thus, was not
typically used with an additional visceral vessel stent. Fi-
nally, a scallop, allowing the incorporation of one or more
vessels, could be carved out of the proximal end of the
fabric with a nominal width of 10 mm and a height ranging
from 6 to 12 mm. The location of the fenestrations and
scallops were customized to fit individual patient anatomy.
Procedure. After femoral artery exposure, patients
were heparinized to maintain activated clotting times
greater than 300 seconds for the duration of the procedure.
A stiff wire was advanced into the aortic arch through the
femoral artery on the intended side of delivery. Two sheaths
were inserted through separate puncture sites into the
contralateral femoral artery. A flush catheter was positioned
immediately above the celiac artery through the contralat-
eral femoral artery. An angled catheter was placed through
the second sheath on the contralateral side and left at the
level of the aortic bifurcation. The first component was
Fig 1. The device pictured is representative of the majority (18) of
implants that were placed in these 22 patients. A three-piece
modular design (A), using a proximal tube graft (B) that included
the customized fenestrations, was coupled with a bifurcation seg-
ment. The intended overlap was quite long (usually in excess of 4
cm), and then mated with an iliac limb of variable length and
diameter.
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oriented, using radio-opaque markers, to accommodate the
incorporated renal and visceral ostia and inserted over the
stiff wire. Partial expansion of the device was then accom-
plished by sheath withdrawal that occurs amid several small
contrast injections (7 cc injected at 30 cc/second) through
the flush catheter. Posterior tethering (Fig 2) prevents
complete expansion of the prostheses after sheath with-
drawal, allowing additional adjustment of the fenestrations
position (rotational and longitudinal movement). Access to
the partially expanded endograft was achieved through
both of the contralateral femoral sheaths with the use of
steerable catheter-guidewire systems. A minimum of two
visceral vessels were then cannulated through the respective
fenestrations from within the prosthesis. Guiding catheters
(8F Multipurpose B Lumex Guiding Catheter; Cook Inc)
were inserted over Rosen wires into both of the accessed
fenestrations (Fig 3). In the setting of significant ostial
stenosis, microcatheter systems (Renegade, Boston Scien-
tific, Boston, Mass) were used in conjunction with Bal-
anced Middle Weight wires (Guidant Inc, Menlo Park,
Calif) and 6F guides that were shape matched to accom-
modate the visceral vessel. The graft material was then fully
expanded by removing the wire tethering the posterior
aspect of the prosthesis. The top cap was then deployed,
Fig 2. A, The posterior sutures tether the graft, providing the ability to partially expand the prosthesis to allow for
cannulation of fenestrated vessels, which serves to ensure proper rotation of the device as it fully expands. B, Renal
fenestrations with four gold markers oriented in a circular manner 90 degrees apart. These markers, in conjunction with a set
of anterior vertically oriented linear markers that are oblique to the set of posterior horizontal markers, are used to help orient
the device prior to deployment (C).
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Fig 3. The standard technique for ensuring the proper orientation of the device after deployment consists of the
placement of guiding catheters or balloons into two vessels (A) prior to removal of the wire maintaining the posterior
tethering sutures. Alternatively, in the setting of an early renal branch or two adjacent renal arteries, the use of kissing
stents can be accomplished with 0.014-inch systems in conjunction with 6F guiding catheters (B-C). Simultaneous
stent (Herculink plus 6.5  18 mm; Guidant, Menlo Park, Calif) inflation and caution when manipulating device or
ballooning the proximal neck will help to ensure preservation of renal blood flow.
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and relatively long (17-mm) balloon-expandable stents
(Double Strut, EV3) were deployed, such that approxi-
mately 12 mm were lodged within the visceral vessel and 5
mm extended into the aorta. The visceral and renal stenting
technique was modified to account for early bifurcations,
ostial stenoses, and severe angulation. The aortic compo-
nent of the balloon-expanded visceral stents were further
dilated to 10 mm and then selectively flared with a compli-
ant latex balloon. The top cap was retrieved while access to
both stented vessels was maintained with the guiding cath-
eters. The guiding catheters were removed after renal an-
giography. The second component of the system was then
inserted through the ipsilateral femoral artery, oriented,
and deployed such that the contralateral limb expanded
immediately above the aortic bifurcation. Contralateral ac-
cess was then obtained through the most proximal of the
contralateral sheaths, and the remainder of the deployment
sequence is similar to the Zenith system.13 Compliant
balloon inflation at all joints and distal sealing zones pre-
ceded completion angiography (Fig 4).
Follow-up imaging. Postoperative evaluation con-
sisted of helical CT studies, duplex ultrasound scan, creat-
inine assessment, and flat plate radiography prior to hospi-
tal discharge (except duplex scan) and at 1, 6, and 12
months. Secondary interventions were indicated in the
setting of a suspected type 1 or 3 endoleak or compromised
visceral or renal flow. The status of each visceral and renal
artery was recorded in addition to the flow velocities mea-
sured. Aneurysm size change, endoleak classification, and
outcome analyses were conducted in accordance with the
reporting standards for endovascular aneurysm repair.14
RESULTS
Patients. A total of 22 patients underwent endovascu-
lar grafting with a fenestrated device. There were 20 men
and 2 women with a mean age of 76  8 years (range,
62-92 years). Preoperative risk factors are listed in Table I.
The abdominal aortic aneurysm (AAA) was associated with
a common iliac aneurysm in two patients, and a thoracic
aneurysm in one patient, all of which were ultimately
repaired with an endovascular approach. The mean proxi-
mal neck diameter was 26 3 mm (range, 21-30 mm) and
proximal neck length 8 5 mm (range, 3-16 mm), respec-
tively. Moderate angulation (40°, 60°) of the proximal
neck was noted in 10 patients and severe angulation
(60°) in 3 patients. Thrombus incorporating greater
than two thirds of the proximal neck circumference was
noted in 10 patients. Overall, 16 patients were treated
with fenestrated grafts because of short proximal necks
(3-10 mm), and 6 patients had compromised quality of
necks with lengths ranging from 10 to 16 mm. Mean
maximum transverse aneurysm diameter was 62  14
mm. Prosthesis designs incorporated a total of 58 vis-
ceral vessels, with a mean number of fenestrations per
patient of 2.6. Table II shows the distribution of renal,
superior mesenteric, and celiac arteries treated. All pros-
theses were implanted successfully without any acute loss of
branches (with the exception of a single accessory renal that
Fig 4. This 67-year-old woman is on home oxygen secondary to chronic obstructive pulmonary disease, and she is a
Jehovah’s Witness. Her preoperative angiogram is demonstrative of a very short neck below the right renal with the aneurysm
incorporating the left renal (A). This represents a complex fenestrated repair, as the fabric must be lodged into the left renal
artery to achieve a complete seal. She was treated with a fenestrated graft with two renal fenestrations and a scallop for the
SMA. She had complete exclusion of the 5.5-cm aneurysm on her completion angiogram (B) and discharge CT scan. The
size of her aneurysm has subsequently decreased to 4.5-cm maximum diameter after 1 year of follow-up.
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was intentionally covered in one patient). Procedural time
averaged 211  55 minutes with a mean of 55  20
minutes of fluoroscopy time. The mean volume of contrast
used was 169  43 mL.
Complementary endovascular procedures were per-
formed with the initial procedure in 11 (50%) patients. The
procedures included the placement of a balloon-expand-
able stent immediately below the renal arteries in three
patients to seal a proximal leak and at the level of the aortic
bifurcation in one patient to seal a distal leak in an aortoaor-
tic device. Wallstents (Boston Scientific, Nadic, Mass) were
implanted into five iliac limbs to alleviate kinking or unac-
ceptable tortuosity after endograft deployment. Endograft
extensions were required in two patients to achieve appro-
priate coverage of the iliac vasculature and adequate device
overlap. Completion angiography demonstrated type 2
endoleaks in five patients. One patient required a femoral
endarterectomy and prosthetic patch closure on the side of
the main delivery system insertion.
Follow-up. There were no acute mortalities or aneu-
rysm related deaths. The postprocedural CT depicted a
type II endoleak in 4 patients, a proximal type I endoleak in
1 patient, and a type III (component-sealing defect) en-
doleak in 1 patient. The later two patients underwent an
early secondary intervention. A balloon-expandable stain-
less steel stent was implanted at the proximal neck in the
first patient, and a complementary extension piece was
implanted increasing the overlap between modular compo-
nents in the second patient, resolving both endoleaks. The
mean follow-up was 6 months (range, 1-12 months). One
patient died 6 months after the initial procedure from
severe coronary insufficiency. There were no aneurysm-
related deaths, and no patients were lost to follow-up.
The 30-day endoleak rate was 9% (2 type II endoleaks).
Sac shrinkage (5 mm) was noted in 53% (9 of 17) of
patients at 6 months and 75% (3 of 4) of patients imaged at
12 months. The remaining patient had an increasing aneu-
rysm size that was attributed to a patent inferior mesenteric
artery. This was treated with transarterial glue embolization
(TrueFill Glue; Cordis Endovascular, Great Lakes, NJ)
after the 12-month CT scan.
Three patients (14%) developed an increase in serum
creatinine (30% over baseline value) during the course of
the follow-up period. One patient had a transient rise from
1.3 mg/dL to 2.7 mg/dL that later diminished to 2.0
mg/dL by the 6-month measurement. A second patient
suffered a ruptured thoracic aortic aneurysm with pro-
longed severe hypotension, incipient renal failure, and right
renal artery occlusion. The rupture was treated with an
endovascular graft, and the patient required hemodialysis
for a period of 2 months before recovering his renal func-
tion. A right renal artery stenosis was diagnosed in a third
patient from the 6-month duplex ultrasound scan. This
stenosis was associated with a significant serum creatinine
rise, which decreased to baseline levels after successful
treatment of the stenosis with angioplasty and stenting. An
additional branch vessel stenosis was detected in one pa-
tient that presented with abdominal pain approximately 30
days after the procedure. Duplex ultrasound scanning dem-
onstrated elevated velocities at the origin of the superior
mesenteric artery (SMA); however, the stenosis was not
visualized angiographically. Intravascular ultrasound scan-
ning demonstrated fabric material partially obstructing the
SMA origin, which was treated successfully with a self-
expanding stent. The primary patency and assisted primary
patency rate of the 58 vessels incorporated in the fenes-
trated endografts, assessed by Kaplan-Meier analysis, were
respectively 97% and 98% at 1 month, and 94% and 98% at
12 months (Fig 5).
DISCUSSION
A great deal of progress has been made since the
inception of endovascular grafting in 1991.15 Complex
anatomies that were previously considered untreatable with
such an approach are now commonly addressed. The pro-
gression from an aortic tube graft to a modular bifurcated
design greatly improved the versatility of this procedure.
Large diameter iliac limbs13 and combined surgical and
endovascular procedures16 have provided a means to ad-
dress most complex iliac anatomy. However, the proximity
of the aneurysm to the visceral vessels has limited the
fixation and sealing potential for most grafts and poses the
Table I. Preoperative comorbidities or risk factors for the
22 patient cohort
No. of
patients %
Arterial hypertension 14 64
Diabetes 3 14
Coronary artery disease 14 64
Renal insufficiency (creatinemia 120 mol/L) 5 23
COPD 16 73
Previous laparotomy 4 18
Obesity (weight 110% ideal body weight) 5 23
Previous stroke 6 27
The predominance of hypertension, severe chronic obstructive pulmonary
disease (COPD), and coronary artery disease (all patients were treated either
medically or surgically for these conditions) characterized most of the
population treated.
Table II. Distribution of vessels incorporated into the
fenestrated devices
Mesenteric fenestrations
Number of renal fenestrations
1 2 3
None 2 5 0
SMA 0 13 1
SMA  CELIAC 0 1 0
Most of the patients had devices involving two main renal arteries and the
SMA. A single patient had a large accessory renal artery that was preserved
with a third renal fenestration, and two patients had renal arteries that were
markedly disparate, requiring only single fenestrations. Only one patient
required incorporation of all four visceral vessels. Fig 5 demonstrates the
patency of the visceral vessels incorporated into the repair. The 12-month
primary patency was 94%, with an assisted primary patency of 98%.
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most frequent contraindication to an endovascular ap-
proach in our institution. Incorporation of such vessels into
an implant design is potentially beneficial, as it extends to
sealing and fixation segments well into the more stable
visceral aorta. However, to achieve a reasonable level of
success, careful planning with attention to patient-specific
anatomy is required, in conjunction with high-resolution
imaging systems, and skilled endovascular teams are re-
quired.
The first reports of the use of fenestrated devices were
published in 1999.17 The experience of Anderson et al11
with 13 cases was associated with no acute loss of branch
vessels, and periprocedural mortality at 30 days was nil.
Stanley et al12 reported a series of three patients also
without vessel loss or death. A number of case reports with
various designs have been published, all with successful
outcomes.18 However, follow-up paradigms and outcome
measures have differed in the various reports, and several
questions as to the durability of such a repair remain.
There exists a substantial population of patients with
aneurysms heretofore untreatable with an endovascular
approach, unfit for open repair, and relegated to medical
management. The expanded versatility of endovascular
grafting has the potential to further diminish aneurysm-
related deaths. However, the relatively high anesthetic risk
in an extremely morbid population that is associated with a
decreased life expectancy and, thus, reduced benefit from
prophylactic treatment, must be considered during the
treatment selection process. Additional concerns with the
durability of such repairs have also resulted in considerable
speculation. The use of suprarenal stenting has been advo-
cated to enhance proximal fixation, particularly when cou-
pled with barbs,19 and was shown to have no detrimental
effect on renal function. However, an adequate region of
proximal sealing is still required and must occur in the
infrarenal position. The addition of fixed diameter fenestra-
tion provides the ability to maintain branch vessel patency.
It also has the potential to ensure a sealing zone that
incorporates the entire infrarenal neck and can extend
proximal to the renal arteries when the graft fabric is
anchored directly to the renal ostium. This technique has
allowed the successful exclusion of aneurysms that, strictly
speaking, may be defined as pararenal aneurysms (as de-
picted in Fig 4) under favorable anatomic conditions.
Despite the extended versatility of this type of prosthe-
sis, anatomic factors can seriously complicate the design
and delivery of the device. After initial graft positioning it is
critical to maintain rotational movement to properly orient
the fenestrations. Significant angulation within the proxi-
mal neck or small diameter, calcific, or overly tortuous iliac
anatomy will hamper this and increase the risk of acute
branch vessel loss. Furthermore, a proximal renal artery
bifurcation, as is frequently seen, undermines the ability to
properly stent the renal artery with a flarable stent. In these
circumstances we have used a kissing stent technique, (Fig
3, B); however, one cannot flare the stents properly, and
this adds a level of complexity to the procedure and might
increase the risk of loss of renal parenchyma. The fenes-
trated procedures take longer on average than conventional
infrarenal endografts and require more fluoroscopy time
and contrast media as well. Thus, in a neck that is felt to be
of good quality, a traditional prosthesis with secure fixation
should be used rather than a fenestrated device.
Renal function remained stable in all but three patients,
two of which were attributable to the procedure. Evalua-
tion techniques for renal artery stenosis and patency were
limited in this study to CT, angiography, and duplex ultra-
sound scanning. However, the significant amount of metal
artifact generated by the renal stents and stent graft pre-
cluded accurate calculations of renal stenosis from cross-
sectional imaging studies. One patient developed a renal
artery stenosis of a previously nonstenosed renal vessel
associated with an elevated serum creatinine 6 months after
implantation of the fenestrated device with a renal stent.
The stenosis and renal insufficiency were remedied by re-
peat angioplasty and stenting; however, the potential for in
stent stenosis mandates careful assessment of the renal and
visceral vessels after device placement. A second patient was
noted to have a periprocedural rise in serum creatine that
was attributed to atheroemboli. Theoretically, the potential
for embolic problems could be greater with this procedure,
owing to the increased amount of manipulation required
within the proximal neck. A third patient was treated with a
fenestrated device for a 9-cm AAA in the setting of a
remote7-cm aneurysm of the mid descending thoracic
aorta. Although an endovascular repair of the thoracic
aneurysm was planned, the patient suffered a thoracic aortic
rupture. A period of prolonged (48 hours) hypotension was
associated with worsening renal function. He underwent an
urgent thoracic aortic endovascular repair, and, at that
time, he was noted to have occlusion of his right renal
artery. He required initial treatment with dialysis but ulti-
mately recovered his renal function.
The definitive nature of the proximal seal is manifest by
the relatively rapid size reduction noted in this small series.
Within 6 months, more than 50% of patients had aneurysms
decreasing 5mm. By 12 months, three of four patients
Fig 5. This expanded axis view demonstrates the primary and
assisted patency of any visceral vessels incorporated into a fenes-
trated repair, as calculated with the Kaplan-Meier method.
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had decreasing aneurysm size, and the remaining patient
was noted to have a type II endoleak. No patients experi-
enced aneurysmal growth. The incidence of endoleaks is
quite low (10%) despite a rigorous high-resolution (1.5
mm reconstruction) CT follow-up protocol. Although the
rate of decrease appears to be faster than nonfenestrated
counterparts, the number of patients treated and follow-up
duration is too short to provide a proper comparison.
Despite the complexity of the planning and intraoper-
ative steps, the use of fenestrated devices has the potential
to become widespread. Fixed imaging systems, well-
stocked procedure rooms (with a variety of guiding cathe-
ters, balloons, stents, microcatheter, and other low-profile
systems) and experienced interventionalists are likely to
achieve success. The backbone of the fenestrated technol-
ogy is derived from the Zenith device, and consequently a
solid understanding of the Zenith delivery system, in con-
junction with significant experience in problem-solving
techniques, will be helpful.
This series demonstrates favorable outcomes of juxta-
renal aneurysm repair with a fenestrated endovascular graft
that incorporates the renal and/or visceral aortic segment
with graft material. The short-term absence of branch
vessel loss, low endoleak incidence, rapid contraction of the
aneurysm sac, and limited need for secondary interventions
support further development and distribution of this de-
vice. However, the procedure remains challenging, the
patient population is relatively unforgiving, and technical
precision is mandatory to achieve a successful outcome.
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DISCUSSION
Dr Roy K. Greenberg. Well, at the time of abstract submis-
sion we had completed the procedure on 22 patients. We have now
performed a total of 44 procedures and have 30 or more planned
for the future. I truly believe that this is a technology that needs to
be more widespread. How to enact this dissemination remains to
be determined.
Dr. Charles Sternbergh (New Orleans, La). I very much
enjoyed that presentation. I agree with you that this technology is
going to be key in increasing the applicability of endovascular
repair for our patients. There is an incorrect but pervasive impres-
sion that suprarenal devices are going to allow treatment of very
adverse anatomy. I think we both know that attitude is going to be
problematic. We need these fenestrated devices to offer a durable
endovascular treatment option.
My question revolves around dissemination of this technol-
ogy. Clearly, we have seen single center reports from you showing
excellent results. How are we going to replicate this result in a
multicenter experience such that we can bring this to a commercial
use?
Dr Greenberg. This is a good question. I share your concerns
about the treatment of proximal necks with suprarenal stent grafts
without fenestrations. I think the first step in the fenestrated
dissemination has to be a frozen device design. The technique itself
is actually not as difficult as it may appear. It is not a procedure that
takes an undue amount of time to size or to place the device once
an endovascular specialist is familiar with the system, but it clearly
relies on a backbone of understanding of the predicate system. If
the fenestrated device is based on a Zenith system, the endovascu-
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lar specialist needs to be quite familiar with the Zenith system for
the procedure to work.
But at the same time, I think that we are on the tip of an
iceberg in terms of training endovascular specialists to do these
procedures. In my opinion the training can be widely dissemi-
nated.
Dr Piergiorgio Cao (Perugia, Italy). I enjoyed very much
your presentation. I have a short technical question.
The Cook company tends to exclude patients with a neck less
than 5 mm. You projected the slide in which the left renal artery
arises below the neck Because you need to have at least a few
millimeters below the lowest renal artery, how could you reach the
sealing? How do you handle this problem? Do you put the Palmaz
stent on that area?
Dr Greenberg. That is a good question. I think the use of
fenestrated devices has caused me to reconsider what defines a
sealing zone. Our protocol calls for a 3-mm proximal sealing zone.
But how we define a proximal neck depends on the specific aortic
morphology in the region of the renal arteries.
It is possible with this device to use the renal stent as a rivet and
actually drag the fabric into the renal artery itself. Thus, when a
stent is flared, the stent functions like a rivet that holds the fabric up
against the wall. If it is functioning like a rivet, it extends the seal
into the renal artery. So, an aneurysm opposite a renal artery, or
abutting a renal artery, might be successfully treated with this
device. However, this is not truly a branch vessel device. I would
not try to use this device in a large aneurysm that incorporated the
renal arteries. But if you can get the fabric into the renal artery
itself, it does seal. Two other patients in our series are similar and
have had successful sealing in the setting of disparate arteries. We
have seen aneurysm shrinkage in all of those cases.
Dr Patrick Clagett (Dallas, Tex). I may have missed it, but
with a lot of these aneurysms there is a considerable amount of
laminated thrombus in the area. Was that the case with these
patients? Do laminated thrombi contraindicate this approach?
Dr Greenberg. It was variable. I think that there is more
manipulation in the proximal neck than with conventional devices.
If there is a lot of thrombus, we may be subjecting patients to a
higher incidence of atheroemboli, which we saw in one patient
with adverse renal function. However, if the device is put in and
oriented properly before being deployed, the amount of rotational
motion is limited, thus reducing the risk of emboli. We continue to
evaluate this risk in the ongoing trails.
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